IMMUNOCOMPROMISED

Clinical trials for IMMUNOCOMPROMISED explained in plain language.

Never miss a new study

Get alerted when new IMMUNOCOMPROMISED trials appear

Sign up with your email to follow new studies for IMMUNOCOMPROMISED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 2 Terminated 1

COVID prevention shot for vulnerable patients shows promise in early trial

Prevention Terminated

This study tested whether a combination of two antibodies (casirivimab and imdevimab) could prevent symptomatic COVID-19 in people with weakened immune systems, such as transplant recipients or cancer patients. Participants received either the antibody shot or a placebo. The stud…

Matched conditions: IMMUNOCOMPROMISED

Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Prevention

Last updated Jun 16, 2026 22:37 UTC

IMMUNOCOMPROMISED

Get alerted when new IMMUNOCOMPROMISED trials appear

COVID prevention shot for vulnerable patients shows promise in early trial